Rivastigmine (sold under the trade name Exelon) is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting. The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.

CAS：123441-03-2
中文别名：利斯的明;N-乙基-N-甲基-氨基甲酸 3-[(S)-1-(二甲氨基)乙基]苯酯;
英文别名：N-Ethyl-N-methylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl-ester;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate;Rivastigmine;
分子式：C18H28N2O8
分子量：400.424
精确质量：400.185
Psa：147.84
Logp：0.6371

UNII：PKI06M3IW0

密度：1.038g/cm3
沸点：316.2ºC at 760mmHg
闪点：145ºC
折射率：1.518
蒸汽压：0.000416mmHg at 25°C